Form 4 for BOLT Bolt Biotherapeutics, Inc.
Accepted 2025-05-05 00:00:00 ET · period of report 2025-05-01 · accession 0000950170-25-063846 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-05-05 | 2024-06-06+ | BOLT | Nemec Sarah | Senior VP, Fin, PAO | P - Purchase | $0.57 | +5,000 | 13.9K | +56% | +$2,850 |
| D | 2025-05-05 | 2025-05-01 | BOLT | Nemec Sarah | Senior VP, Fin, PAO | A - Grant | $0.00 | +226.0K | 226.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-16 | P | A | 2,500 | $0.5 | 16,633 | D | — | — | (F2) Shares acquired under the issuer's Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2024-06-06 | P | A | 2,500 | $0.64 | 13,863 | D | — | — | (F2) Shares acquired under the issuer's Employee Stock Purchase Plan. |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-05-01 | A | A | 226,000 | $0.00 | 226,000 | D | $0.35 · — to 2035-04-30 | 226,000 Common Stock | (F3) For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2025. |